Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
FTE cells had a specific induction of CA125 after miR-200 precursor transfection.
»
06/17/17
Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
Akt1 knockdown in PCa cells results in increased production of TGFβ1 and its receptor TGFβ RII.
»
04/26/17
Quantification of microRNA-21 and microRNA-125b in melanoma tissue.
miR-21 ISH was increased in melanomas.
»
06/15/17
Zinc induces apoptosis on cervical carcinoma cells by p53-dependent and -independent pathway.
Intracellular zinc accumulation induced the down-regulation of E6/E7 proteins.
»
12/06/16
Cancer incidence in cohorts of workers in the rubber manufacturing industry first employed since 1975 in the UK and Sweden.
No statistically significant increased risk was observed for any site of cancer.
»
07/27/16
Physical Exercise Positively Influences Breast Cancer Evolution.
Acute and chronic symptoms of breast cancer may all be favorably influenced by regular exercise.
»
10/11/16
Arl13b promotes gastric tumorigenesis by regulating Smo trafficking and activation of the Hedgehog signaling pathway.
Arl13b stimulated proliferation, migration and invasion in vitro and in vivo.
»
06/05/17
Autocrine BMP-4 signaling is a therapeutic target in colorectal cancer.
Inhibition of autocrine BMP-4 as a candidate treatment strategy for CRC.
»
06/05/17
LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4
LPS stimulation appeared to be largely TLR4-dependent.
»
06/22/17
Current guidelines for
BRCA
testing of breast cancer patients are insufficient to detect all mutation carriers
Common guidelines for testing identified 45-90%.
»
06/21/17
< Prev
Next >